INMDInMode Ltd.

Nasdaq inmodemd.com


$ 19.05 $ 1.23 (6.9 %)    

Tuesday, 16-Jul-2024 15:59:50 EDT
QQQ $ 496.22 $ 0.19 (0.04 %)
DIA $ 409.69 $ 7.30 (1.81 %)
SPY $ 564.93 $ 3.33 (0.59 %)
TLT $ 94.14 $ 1.31 (1.41 %)
GLD $ 228.28 $ 4.46 (1.99 %)
$ 19.06
$ 17.95
$ 0.00 x 0
$ 0.00 x 0
$ 17.95 - $ 19.08
$ 16.44 - $ 48.25
1,185,800
na
1.6B
$ 1.85
$ 8.09
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-overweight-on-inmode-lowers-price-target-to-29

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $33 to $29.

 canaccord-genuity-maintains-hold-on-inmode-lowers-price-target-to-16

Canaccord Genuity analyst Caitlin Cronin maintains InMode (NASDAQ:INMD) with a Hold and lowers the price target from $21 to ...

 needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
07/11/2024 15:11:40

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

 inmode-sees-q2-revenue-between-862m-863m-pro-forma-revenue-between-1024m-1025m-vs-11658m-est-decreases-fy-2024-guidance-to-430m-440m-vs-4795m-est

Expects Q2 Revenue Between $86.2M-$86.3M, Pro-Forma Revenue (including new platform pre-orders) Between $102.4M-$102.5M, Decrea...

 needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
05/03/2024 10:17:23

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

 inmode-q1-adj-032-misses-044-estimate-sales-8028m-miss-9302m-estimate

InMode (NASDAQ:INMD) reported quarterly earnings of $0.32 per share which missed the analyst consensus estimate of $0.44 by 27....

 inmode-defends-its-feminine-rejuvenation-patent-against-btl-industries-review-request

InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, responded to the recent petition to th...

 barclays-maintains-overweight-on-inmode-lowers-price-target-to-33

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $34 to $33.

 btl-petitions-uspto-to-cancel-all-58-claims-of-us-patent-no-8961511-owned-by-the-company-inmode-ltd

BTL Industries, Inc., a leading provider of innovative medical aesthetic solutions, petitioned the U.S. Patent Office to cancel...

 why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

 needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
04/09/2024 15:53:24

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

 maxeon-solar-technologies-neogen-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 0.2% on Tuesday. Shares of Maxeon Solar...

 why-fluor-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

 inmode-q4-adj-eps-071-beats-067-estimate-sales-12678m-beat-12504m-estimate

InMode (NASDAQ:INMD) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.67 by 5.97 ...